Trial Profile
Feasibility and Effects on Markers in Spinal Fluid in Persons With Early Alzheimer's Disease When Treated With Valaciclovir - Open Fas II Pilot Study (VALZ-Pilot)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary)
- Indications Alzheimer's disease; Herpes simplex virus infections
- Focus Therapeutic Use
- Acronyms VALZ-Pilot
- 27 Aug 2021 Planned number of patients changed from 36 to 120.
- 01 Apr 2020 Status changed from recruiting to completed.
- 19 Nov 2019 Planned End Date changed from 1 Apr 2019 to 1 Apr 2020.